Supreme Court’s Consideration Of ACA’s “Individual Mandate” Has Three Possible Outcomes

At stake is the requirement for individuals to purchase health insurance and whether that provision is severable from the rest of the Affordable Care Act. From the pharmaceutical industry’s perspective, the most disruptive outcome would be to have the entire law overturned.